Association of Cardiac Rehabilitation With All-Cause Mortality Among Patients With Cardiovascular Disease in the Netherlands

被引:72
|
作者
Eijsvogels, Thijs M. H. [1 ]
Maessen, Martijn F. H. [1 ,2 ]
Bakker, Esmee A. [1 ,3 ]
Meindersma, Esther P. [4 ]
van Gorp, Niels [2 ]
Pijnenburg, Nicole [2 ]
Thompson, Paul D. [5 ]
Hopman, Maria T. E. [1 ]
机构
[1] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Dept Physiol, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands
[2] Cooperatie Volksgezondheidszorg, Business Intelligence Serv, Arnhem, Netherlands
[3] Liverpool John Moores Univ, Res Inst Sports & Exercise Sci, Liverpool, Merseyside, England
[4] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Dept Cardiol, Med Ctr, Nijmegen, Netherlands
[5] Hartford Hosp, Div Cardiol, Hartford, CT 06115 USA
关键词
HEART-FAILURE; EXERCISE; GUIDELINES; RISK; PARTICIPATION; METAANALYSIS; PROGRAMS;
D O I
10.1001/jamanetworkopen.2020.11686
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This cohort study investigates the implications of sex, age, socioeconomic status, cardiovascular disease (CVD) diagnosis, cardiothoracic surgery, and comorbidity for the association between cardiac rehabilitation participation and all-cause mortality. Importance Cardiac rehabilitation (CR) is an effective strategy to improve clinical outcomes, but it remains underused in some subgroups of patients with cardiovascular disease (CVD). Objective To investigate the implications of sex, age, socioeconomic status, CVD diagnosis, cardiothoracic surgery, and comorbidity for the association between CR participation and all-cause mortality. Design, Setting, and Participants Observational cohort study with patient enrollment between July 1, 2012, and December 31, 2017, and a follow-up to March 19, 2020. The dates of analysis were March to May 2020. This study was performed among Dutch patients with CVD with a multidisciplinary outpatient CR program indication and who were insured at Cooperatie Volksgezondheidszorg, one of the largest health insurance companies in the Netherlands. Among 4.1 million beneficiaries, patients with CVD with an acute coronary event (myocardial infarction or unstable angina pectoris), stable angina pectoris, chronic heart failure, or cardiothoracic surgery (coronary artery bypass grafting, valve replacement, or percutaneous coronary intervention) were identified by inpatient diagnosis codes and included in the study. Main Outcomes and Measures Cox proportional hazards models were used to evaluate the association between CR participation and all-cause mortality. Stabilized inverse propensity score weighting was used to account for patient and disease characteristics associated with CR participation. Results Among 83687 eligible patients with CVD (mean [SD] age, 67 [12] years; 60.4% [n = 50 512] men), only 31.3% (n = 26171) participated in CR, with large variation across different subgroups (range, 5.1%-73.0%). During a mean (SD) of 4.7 (1.8) years of follow-up, 1966 CR participants (7.5%) and 13443 CR nonparticipants (23.4%) died. After multivariable adjustment, CR participation was associated with a 32% lower risk of all-cause mortality (adjusted hazard ratio, 0.68; 95% CI, 0.65-0.71) compared with nonparticipation. Sex, age, socioeconomic status, and comorbidity did not alter risk reduction after CR participation, but a statistically significant interaction association was found across categories of CVD diagnosis and cardiothoracic surgery. Larger reductions in risk estimates for all-cause mortality were found after CR participation for STEMI (adjusted HR, 0.59; 95% CI, 0.52-0.68 vs 0.72; 95% CI, 0.65-0.79; P < .001), NSTEMI (adjusted HR, 0.64; 95% CI, 0.58-0.70 vs 0.72; 95% CI, 0.65-0.79; P < .001), and stable AP (adjusted HR, 0.69; 95% CI, 0.63-0.76 vs 0.72; 95% CI, 0.65-0.79; P < .001) compared with patients with chronic heart failure, whereas unstable AP had a smaller risk reduction (adjusted HR, 0.75; 95% CI, 0.67-0.85 vs 0.72; 95% CI, 0.65-0.79; P < .001). Conclusions and Relevance In this cohort study, CR participation was associated with a 32% risk reduction in all-cause mortality, and this benefit was independent of sex, age, socioeconomic status, and comorbidity. These findings reinforce the importance of CR participation in secondary prevention and highlight the possibility that CR should be prescribed more widely to vulnerable patients with CVD, such as older adults with chronic diseases or multimorbidity. Question What is the patient-specific, disease-specific, and comorbidity-specific association of cardiac rehabilitation participation with all-cause mortality? Findings In this cohort study, 31% of 83687 eligible patients with cardiovascular disease participated in a multidisciplinary outpatient cardiac rehabilitation program. Cardiac rehabilitation participation was associated with a 32% lower risk of all-cause mortality compared with nonparticipation, which was independent of patient-related and comorbidity-related characteristics. Meaning Cardiac rehabilitation participation is associated with a lower mortality risk compared with nonparticipation; however, cardiac rehabilitation remains underused, especially in older adults with chronic diseases or multimorbidity.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Exercise-Based Cardiac Rehabilitation and All-Cause Mortality Among Patients With Atrial Fibrillation
    Buckley, Benjamin J. R.
    Harrison, Stephanie L.
    Fazio-Eynullayeva, Elnara
    Underhill, Paula
    Lane, Deirdre A.
    Thijssen, Dick H. J.
    Lip, Gregory Y. H.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (12):
  • [22] The association of depression with all-cause and cardiovascular disease mortality risk among transgender and gender diverse and cisgender patients
    Wolfe, Hill L.
    Boyer, Taylor L.
    Henderson, Emmett R.
    Streed Jr, Carl G.
    Blosnich, John R.
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 366 : 364 - 369
  • [23] Association of Prevalent Kidney Stone Disease with All-Cause and Cardiovascular Disease Mortality among US Adults
    Shringi, Sandipan
    Raker, Christina A.
    Tang, Jie
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [24] Diabetes modifies the association of prehypertension with cardiovascular disease and all-cause mortality
    Ren, Yanlong
    Zuo, Yingting
    Wang, Anxin
    Chen, Shuohua
    Tian, Xue
    Li, Haibin
    He, Yan
    Wu, Shouling
    Ma, Changsheng
    JOURNAL OF CLINICAL HYPERTENSION, 2021, 23 (06): : 1221 - 1228
  • [25] Association of Cycling With All-Cause and Cardiovascular Disease Mortality Among Persons With Diabetes-Reply
    Ried-Larsen, Mathias
    Rasmussen, Martin Gillies
    Grontved, Anders
    JAMA INTERNAL MEDICINE, 2021, 181 (12) : 1678 - 1679
  • [26] Risk of Secondary Cardiovascular Disease and All-Cause Mortality among Patients with and without Diabetes
    Nichols, Gregory A.
    Pedula, Kathryn L.
    Wang, Fang
    Bell, Timothy J.
    DIABETES, 2009, 58 : A27 - A27
  • [27] Association of Tramadol With All-Cause Mortality Among Patients With Osteoarthritis
    Zeng, Chao
    Dubreuil, Maureen
    LaRochelle, Marc R.
    Lu, Na
    Wei, Jie
    Choi, Hyon K.
    Lei, Guanghua
    Zhang, Yuqing
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (10): : 969 - 982
  • [28] Association of body roundness index with cardiovascular disease and all-cause mortality among Chinese adults
    Lin, Hong
    Jia, Xiaojing
    Yin, Yue
    Li, Mian
    Zheng, Ruizhi
    Xu, Yu
    Wang, Shuangyuan
    Xu, Min
    Wang, Tiange
    Zhao, Zhiyun
    Zheng, Jie
    Shen, Feixia
    Gu, Xuejiang
    Mu, Yiming
    Chen, Lulu
    Zeng, Tianshu
    Shi, Lixin
    Su, Qing
    Chen, Yuhong
    Yu, Xuefeng
    Yan, Li
    Qin, Guijun
    Wan, Qin
    Chen, Gang
    Tang, Xulei
    Gao, Zhengnan
    Hu, Ruying
    Luo, Zuojie
    Qin, Yingfen
    Chen, Li
    Hou, Xinguo
    Huo, Yanan
    Li, Qiang
    Wang, Guixia
    Zhang, Yinfei
    Liu, Chao
    Wang, Youmin
    Wu, Shengli
    Yang, Tao
    Deng, Huacong
    Zhao, Jiajun
    Ning, Guang
    Bi, Yufang
    Wang, Weiqing
    Lu, Jieli
    DIABETES OBESITY & METABOLISM, 2025, 27 (05): : 2698 - 2707
  • [29] Association between the dietary inflammatory index and all-cause and cardiovascular mortality in patients with atherosclerotic cardiovascular disease
    Yang, Mingkun
    Miao, Shenhui
    Hu, Weihang
    Yan, Jing
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2024, 34 (04) : 1046 - 1053
  • [30] Association of Serum Procalcitonin with All-Cause and Cardiovascular Mortality in Patients with ESKD
    Sinojia, Kishan
    Mallisetty, Yamini
    Han, Zhongji
    Chiu, ChiYang
    Seegmiller, Jesse C.
    Karger, Amy B.
    Kovesdy, Csaba
    Sumida, Keiichi
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):